KIMBERLEE WILCOX: Open Payments
NPI 1427142140 · NORTH VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 40 payments from 15 companies in 2025. Trend: 2023 $1,580 · 2024 $1,318 · 2025 $2,122
Food & beverage: $2,122
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $395 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $246 |
| Boston Scientific Corporation | 2 | $241 |
| Lundbeck LLC | 2 | $219 |
| Alnylam Pharmaceuticals Inc. | 3 | $206 |
| Novo Nordisk Inc | 4 | $186 |
| CVRx, Inc. | 1 | $177 |
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| Pulmonx Corporation | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
Products named: REPATHA, LifeVest, Wegovy, Barostim Neo System, General - Therapies, AMVUTTRA, VYEPTI, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
